Inhibition of P2X7 receptors on VSMCs, ECs, cardiomyocytes, and cardiac fibroblast has been deemed beneficial in attenuating hypertension, excessive inflammatory response, and developing myocardial fibrosis [108,138,187,224]. This evidence concerns the gene P2RX7 and hypertensive disorder.